# Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Source: https://onco.cc/trials/nct04365374/  
OnCo record `nct04365374` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) in brain and spinal cord tumours, run by GT Medical Technologies, Inc., active and no longer recruiting.

## Summary

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study) is a phase 3 interventional study registered as NCT04365374 by GT Medical Technologies, Inc., with 230 participants enrolled, started 2021-04-06 and due to reach its primary completion in 2029-08-30. Interventions recorded: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) and Stereotactic Radiation Therapy.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04365374
- Phase: 3
- Setting: A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (STaRT) With Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.
- Sponsor: GT Medical Technologies, Inc.
- Enrolled: 230

## Sources

- ClinicalTrials.gov NCT04365374: https://clinicaltrials.gov/study/NCT04365374

## Connected records

- cancers: [Brain and spinal cord tumours (all types)](https://onco.cc/cancers/brain-tumours/)
- companies: [GT Medical Technologies](https://onco.cc/companies/gt-medical-technologies/)

---
JSON: https://onco.cc/api/v1/entities/nct04365374.json